Dentsply Sirona Keeps Quarterly Dividend at $0.16 Per Share, Payable July 12 to Shareholders of Record June 28
05:02 PM EDT, 05/22/2024 (MT Newswires) -- Dentsply Sirona Keeps Quarterly Dividend at $0.16 Per Share, Payable July 12 to Shareholders of Record June 28
Press Release: Dentsply Sirona Declares Quarterly Cash Dividend
Dentsply Sirona Declares Quarterly Cash Dividend CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) announced that its Board of
Analysts' Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Acumen Pharmaceuticals (ABOS) and DENTSPLY SIRONA (XRAY)
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)
Stifel Nicolaus Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)
Dentsply Sirona to Participate in Upcoming Investor Conferences
CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Bank of America
Dentsply Sirona Is Maintained at Neutral by Goldman Sachs
Dentsply Sirona Is Maintained at Neutral by Goldman Sachs
Express News | Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $30
Dentsply Sirona Is Maintained at Outperform by Evercore ISI Group
Dentsply Sirona Is Maintained at Outperform by Evercore ISI Group
Earnings Call Summary | Dentsply Sirona(XRAY.US) Q1 2024 Earnings Conference
The following is a summary of the DENTSPLY SIRONA Inc. (XRAY) Q1 2024 Earnings Call Transcript:Financial Performance:DENTSPLY SIRONA reported Q1 2024 revenue of $953 million, a decline of 2.6% from th
Express News | Evercore ISI Group Maintains Outperform on Dentsply Sirona, Lowers Price Target to $35
UBS Adjusts Price Target on Dentsply Sirona to $37 From $38, Maintains Buy Rating
Dentsply Sirona (XRAY) has an average outperform rating and a price target range of $27 to $42, according to analysts polled by Capital IQ. Price: 28.52, Change: +0.14, Percent Change: +0.49
Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Appear To Be Weighed Down
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and th
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Dentsply Sirona Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target price by $1
DENTSPLY SIRONA: A Buy Rating With Positive Long-Term Growth Prospects Despite Short-Term Challenges
Express News | Dentsply Sirona Inc : Barrington Research Cuts Target Price to $38 From $41
Challenging Growth and Market Pressures Lead to Hold Rating for DENTSPLY SIRONA
Dentsply Sirona Price Target Cut to $33.00/Share From $35.00 by Baird
Dentsply Sirona Price Target Cut to $33.00/Share From $35.00 by Baird
Dentsply Sirona Is Maintained at Buy by Needham
Dentsply Sirona Is Maintained at Buy by Needham
Express News | Needham Maintains Buy on Dentsply Sirona, Lowers Price Target to $36